RxDoctor Payments Data

Laura Davide

Physician Assistant · Melville, NYNPI 1578771895

Payments from drug & device makers

$10,311in general payments, 2019–2025

Across 310 payments — averaging $33.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$2K
  • Lundbeck LLC$1K
  • Amgen$908
  • Otsuka America Pharmaceutical, Inc.$584
  • Novo Nordisk$570
  • plus $3K from 26 others

What the payments were for

  • Food & beverage$10,311100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,311 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan15$13,483
OzempicSemaglutide15$12,689
JardianceEmpagliflozin15$12,197
Repatha SureclickEvolocumab13$7,338
Levothyroxine Sodium125$2,189
Atorvastatin Calcium184$1,707
Olmesartan Medoxomil45$1,396
SynthroidLevothyroxine Sodium21$1,045
Albuterol Sulfate HfaAlbuterol Sulfate39$1,014
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide28$972
Omeprazole65$805
Metoprolol Succinate40$698
Nebivolol Hcl11$668
Bupropion XlBupropion Hcl17$649
Rosuvastatin Calcium93$639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$570$12,68915 claims
AbbVieSynthroid$1,949$1,04521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Melville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →